Tafamidis Helps More Heart Amyloid Patients Keep Their Walking Distance, Analysis Finds
A post hoc analysis of the ATTR-ACT trial found that 64 percent of tafamidis-treated patients maintained walking-distance stability at 12 ...
A post hoc analysis of the ATTR-ACT trial found that 64 percent of tafamidis-treated patients maintained walking-distance stability at 12 ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.